USC research identifies how genetic mutations affect cancer treatment efficacy. * Analysis of 78,000+ patients across 20 cancer types. * Identified 95 genes linked to survival rates in breast, ovarian, skin, and gastrointestinal cancers. * KRAS gene mutations correlate with poor response to EGFR inhibitors in NSCLC. * NF1 gene mutations improve immunotherapy response but compromise targeted therapy efficacy. * Developed machine-learning tool to predict immunotherapy response in advanced lung cancer.
USC Study Reveals Genetic Mutations Impact Cancer Treatment Efficacy: Personalized Medicine Advances with Predictive Machine Learning Tool
Read more news on this topic:
Noise Partners with Bose for Premium Master Buds, Featuring 49dB ANC, Spatial Audio, and Dual Device Connectivity
Samsung Dominates TV Market with Quantum Dot Technology and Enhanced Security Features in Smart TVs
Google Expands 'School Time' Mode to Android Devices and Simplifies Family Link for Enhanced Parental Controls
Did you find an error or inaccuracy?
We will consider your comments as soon as possible.